Below are your results for the search term: "cardiac"
Search Again Back to previous page
1 - 50 results more>>- 1. Lateral Flow Technology and the Future of Point of Care Diagnostics
- 2. Worldwide Point of Care Diagnostics (POC): Are Decentralized Clinical Diagnostics a Cost Drain or Revenue Driver?
- 3. The Worldwide Market for In Vitro Diagnostic Tests
- 4. Cardiovascular Drug Delivery - technologies,markets and companies
- 5. Cell Therapy - Technologies, Markets and Companies
- 6. Key Diagnostic Testing Markets
- 7. Cardiac Marker Diagnostic Testing Markets
- 8. Diabetes, Metabolic Syndrome and Cardiovascular Disease
- 9. Disposable Medical Supplies Markets
- 10. High-Growth Diagnostic Testing Markets
- 11. Point of Care Diagnostic Testing Sector Trends
- 12. Blood Glucose Testing and Diabetes Management
- 13. RNA Interference Markets
- 14. The World Market for In Vitro Diagnostics, 2005
- 15. Stem Cells - Business opportunities and forecasts
- 16. Tissue Engineering and Stem Cell Technology Report 2007
- 17. Cardiac Rhythm Management Devices World Markets: Defibrillators, Pacemakers and Leads
- 18. U.S. Market for Home Care Products
- 19. Physician Office Laboratory (POL) Testing Markets Worldwide: Status Quo and Future Trends
- 20. Respiratory Syncytial Virus (RSV) - A market yet to reach its full potential
- 21. Atherosclerosis - HDL, ApoA-I, Carotid MRI and 64-slice CT offer opportunities
- 22. Osteoarthritis - The Wait for a DMOAD Continues
- 23. Atrial Fibrillation - Limited efficacy and poor safety lead to bleak outlook
- 24. Pipeline Insight: Breast Cancer - A diverse and increasingly crowded pipeline
- 25. Pipeline Insight: Cancer Overview Emerging Therapeutic and Commercial Opportunities
- 26. Pipeline Insight: Antiarrhythmics - RSD1235 in a class of its own
- 27. Optimizing Targeted Treatment in Cancer: Negotiating the Challenges to Success
- 28. Stakeholder Insight: Heart Failure
- 29. Pipeline Insight: Hepatitis C - Small Molecules, Big Revolution?
- 30. The World Cardiovascular Drug Market: Antihypertensives, Antihyperlipidemics, Vasodilators, Anticoagulants, Diuretics and other Agents
- 31. The World Hypertension Market 2007-2023
- 32. Pediatric Drugs - the Worldwide Market
- 33. Ventricular Fibrillation and Atrial Fibrillation
- 34. Histone deacetylase inhibitors
- 35. 2003 Cardiovascular Market Update
- 36. Stakeholder Insight: Atrial Fibrillation - Future Advances in Stroke Prevention
- 37. Cardiovascular Disease: The 45+ Market in the United States for Drugs and Medical Devices
- 38. The Worldwide Market for In Vitro Diagnostic Tests, 4th Edition
- 39. Ultrasound Markets
- 40. Congestive Heart Failure: Major World Markets - Devices (Pacemaker, ICD, LVAD and Artificial Heart Markets)
- 41. The World Market for Catheters
- 42. Stakeholder Insight: Acute Coronary Syndromes Fresh look at ACS in Europe, what is the real picture
- 43. Congestive Heart Failure: Major World Markets - Pharmaceutical Management
- 44. Percutaneous Coronary Intervention
- 45. Pipeline Insight: Nosocomial Vaccines
- 46. Heart Failure - Therapeutic Options
- 47. Major World Markets for Stents and The Economics of Drug-Eluting Technology
- 48. The Worldwide Market for In Vitro Diagnostic Tests
- 49. Major World Markets for Stents and The Economics of Drug-Eluting Technology
- 50. AVANT Immunotherapeutics Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials
1 - 50 results more>>